In Vitro Fertilization (IVF) Market
Opportunity Analysis and Industry Forecast, 2014-2022
The IVF market in Europe is characterized by factors such as lower fertility rates, delayed marriages, and late parenthood decisions. Subsidization of IVF treatments in Germany owing to the lowest birthrate of ~1.46 children/women is a major driving factor for the growth of this market. In addition, the National Health Plan (NHP) covers about 50% of the total treatment cost and pays for three IVF cycles, which is expected to boost the IVF market, especially in Germany. However, lack of reimbursements and high cost of the procedure limit the growth of the European IVF market.
The European IVF Market was valued at $3,054 million in 2015 and is estimated to reach $4,447 million by 2022, growing at a CAGR of 5.4% during the analysis period. In vitro fertilization is a type of assisted reproductive technology-based fertility treatment across the clinical industry. Delayed pregnancy in women is a major factor that drives the IVF market, as the chances of conceiving lowers with age. The success rate of getting pregnant with IVF technique is higher in the age group of 35-39 years.
European IVF Market
IVF Success Rates According to Age in the UK Â
Key Benefits for Stakeholders: • This report provides an in-depth analysis of the European IVF market across eight major countries along with cross-sectional analysis of the total number of IVF cycles performed and the total revenue generated during the forecast period. • It includes the strategies adopted by various IVF clinics and hospitals across major countries to capitalize on the latent opportunities in the market. • The projections are made by analyzing the current market trends and highlighting the market potential, in terms of value and volume, from 2015 to 2022. • Extensive analysis of the market is conducted by following the key product positioning and monitoring the top contenders.
Denmark In Vitro Fertilization Market, Volume and Value, 2014-2022 (Thousand, $Million)
Top Key Player’s in this Market • Thermo Fisher Scientific Inc. • DRK Kliniken Berlin • Sun Pharmaceutical Industries Ltd. • Cadila Healthcare Ltd. • LG Life Sciences • EMD Serono Inc
Europe In Vitro Fertilization (IVF) Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022
VIEW REPORT